BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18377424)

  • 21. Rhabdomyosarcoma in children - current pathologic and molecular classification.
    Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D
    Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
    Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X
    Tumori; 2010; 96(1):90-6. PubMed ID: 20437864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
    de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
    Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
    Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
    Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance related molecules in human and murine lung.
    Scheffer GL; Pijnenborg AC; Smit EF; Müller M; Postma DS; Timens W; van der Valk P; de Vries EG; Scheper RJ
    J Clin Pathol; 2002 May; 55(5):332-9. PubMed ID: 11986335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
    Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
    Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
    Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y
    Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
    Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L
    Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
    Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
    Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T
    Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
    Yamashita T; Higashi M; Momose S; Morozumi M; Tamaru JI
    Int J Oncol; 2017 Aug; 51(2):579-586. PubMed ID: 28714514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma].
    Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.
    Nishimura R; Takita J; Sato-Otsubo A; Kato M; Koh K; Hanada R; Tanaka Y; Kato K; Maeda D; Fukayama M; Sanada M; Hayashi Y; Ogawa S
    Cancer Sci; 2013 Jul; 104(7):856-64. PubMed ID: 23578105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
    Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
    Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy.
    Banerjee Dixit A; Sharma D; Srivastava A; Banerjee J; Tripathi M; Prakash D; Sarat Chandra P
    Seizure; 2017 Apr; 47():9-12. PubMed ID: 28273590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.